These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6423374)

  • 1. Suppressive effect of elcatonin, an eel calcitonin analogue, on excessive urinary hydroxyproline excretion in polyostotic fibrous dysplasia (McCune-Albright's syndrome).
    Yamamoto K; Maeyama I; Kishimoto H; Morio Y; Harada Y; Ishitobi K; Ishikawa J
    Endocrinol Jpn; 1983 Oct; 30(5):651-6. PubMed ID: 6423374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia.
    Bell NH; Avery S; Johnston CC
    J Clin Endocrinol Metab; 1970 Sep; 31(3):283-90. PubMed ID: 4916538
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of Albright's syndrome treated with calcitonin.
    Hjelmstedt A; Ljunghall S
    Acta Orthop Scand; 1979 Jun; 50(3):251-3. PubMed ID: 474095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyostotic fibrous dysplasia with contrasting responses to calcitonin and mithramycin: aetiological and therapeutic implications.
    Long A; Loughlin T; Towers RP; McKenna TJ
    Ir J Med Sci; 1988 Jul; 157(7):229-34. PubMed ID: 2971632
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of alendronate on plasma calcium levels, urinary calcium excretion, and bone resorption markers in normal rats: comparison with elcatonin, synthetic eel calcitonin.
    Azuma Y; Chokki M; Ohta T; Kiyoki M
    Endocrinology; 1996 Jun; 137(6):2586-92. PubMed ID: 8641213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. POLYOSTOTIC FIBROUS DYSPLASIA (ALBRIGHT'S SYNDROME); A CASE REPORT.
    BUKER RH; HUGHES FA; MASHBURN JD
    J Thorac Cardiovasc Surg; 1965 Feb; 49():241-6. PubMed ID: 14256325
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of calcitonin in metastatic bone carcinoma, osteoporosis, polyostotic fibrous dysplasia and hypercalcemia.
    Morii H; Tanae A; Ibayashi H; Nakao K
    Endocrinol Jpn; 1971 Feb; 17(6):81-90. PubMed ID: 4254451
    [No Abstract]   [Full Text] [Related]  

  • 8. Accelerated bone turnover in pregnant women with McCune-Albright syndrome.
    Osada H; Sakamoto R; Seki K; Sekiya S
    Gynecol Obstet Invest; 2005; 60(2):102-7. PubMed ID: 15860920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. McCune-Albright's syndrome.
    Laditan AA; Ofodile F; Osinusi KO; Oluwasanmi JO
    J Natl Med Assoc; 1981 Dec; 73(12):1154-6. PubMed ID: 7328692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary bone dysplasia with hyperphosphatasaemia: response to synthetic human calcitonin.
    Horwith M; Nunez EA; Krook L; Viteri F; Torun B; Mena E; Suh SM; Eisenberg E; MacIntyre I; Whalen JP
    Clin Endocrinol (Oxf); 1976; 5 Suppl():341S-352S. PubMed ID: 1052783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of prolonged thyrocalcitonin administration on Paget's disease of bone.
    Haddad JG; Birge SJ; Avioli LV
    N Engl J Med; 1970 Sep; 283(11):549-55. PubMed ID: 5450609
    [No Abstract]   [Full Text] [Related]  

  • 12. Polyostotic fibrous dysplasia (Albright's syndrome).
    PATTEN RF
    Clin Proc Child Hosp Dist Columbia; 1946 Jul; 2(8):175-84. PubMed ID: 20275891
    [No Abstract]   [Full Text] [Related]  

  • 13. [Unilateral polyostotic fibrous dysplasia and Albright's syndrome].
    DE VULPIAN P; KIRSCH J
    J Radiol Electrol Arch Electr Medicale; 1951; 32(9-10):785-7. PubMed ID: 14909043
    [No Abstract]   [Full Text] [Related]  

  • 14. Albright's syndrome in a four-months-old girl.
    PANDE H
    Acta Paediatr (Stockh); 1959 Jul; 48():397-402. PubMed ID: 14430103
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic bones diseases in practice. Osteoporosis, Paget's disease, von Recklinghausen's disease, and Albright's syndrome.
    GORDAN GS
    Am Pract Dig Treat; 1951 Feb; 2(2):113-9. PubMed ID: 14799735
    [No Abstract]   [Full Text] [Related]  

  • 16. [Polyostotic fibrous dysplasia (Albright's syndrome); review and two case reports].
    SKANSE B; LANGELAND P; VON ROSEN S
    Nord Med; 1956 Jun; 55(24):833-7. PubMed ID: 13348922
    [No Abstract]   [Full Text] [Related]  

  • 17. Endocrine features in Albright's syndrome (fibrous dysplasia of bone).
    BENEDICT PH
    Metabolism; 1962 Jan; 11():30-45. PubMed ID: 13867139
    [No Abstract]   [Full Text] [Related]  

  • 18. [Asu(1,7)E-CT, an analog of eel calcitonin. A comparative study in man with reference to other synthetic calcitonins].
    Caniggia A; Nuti R; Vattimo A; Galli M; Turchetti V; Franci B; Martorelli T; Righi G
    Minerva Med; 1983 Apr; 74(18):993-1010. PubMed ID: 6087215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Short-term biological effects of synthetic salmon calcitonin in Paget's disease. Influence of posology].
    Chapuy MC; Meunier P; Terrier M; David L; Vignon G
    Pathol Biol (Paris); 1975 May; 23(5):349-59. PubMed ID: 172838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyostotic fibrous dysplasia. (Albright's disease) Report of a case and review of the disease.
    MINAISY A
    J Egypt Med Assoc; 1950; 33(8-9):785-90. PubMed ID: 14804606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.